|
|
||||||||
The Annals of Thoracic Surgery, Vol 23, 323-326, Copyright © 1977 by The Society of Thoracic Surgeons
GL Larsen, JA Alexander and W Stanford
Seventy-two patients with Starr-Edwards aortic prostheses of the 2300
series were followed for 1 to 73 months (average, 22 months) without
receiving anticoagulants. Nine patients had clinical evidence of an embolic
episode (12.5%). One of these patients died, and 5 were left with a
significant residual neurological deficit. Two other patients had
hemiparesis but recovered fully. Only 1 episode could be considered minor.
The reported lower incidence of thromboembolism in patients receiving this
prosthesis with adequate anticoagulation has now led us to reverse our
previous position and recommend anticoagulation for patients receiving
Starr-Edwards aortic prostheses.
ARTICLES
Thromboembolic phenomena in patients with prosthetic aortic valves who did not receive anticoagulants
This article has been cited by other articles:
![]() |
A. S. Dunn, J. Wisnivesky, W. Ho, C. Moore, T. McGinn, and H. S. Sacks Perioperative Management of Patients on Oral Anticoagulants: A Decision Analysis Med Decis Making, July 1, 2005; 25(4): 387 - 397. [Abstract] [PDF] |
||||
![]() |
D. Hering, C. Piper, R. Bergemann, C. Hillenbach, M. Dahm, C. Huth, and D. Horstkotte Thromboembolic and Bleeding Complications Following St. Jude Medical Valve Replacement: Results of the German Experience With Low-Intensity Anticoagulation Study Chest, January 1, 2005; 127(1): 53 - 59. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Eckman, H. J. Levine, and S. G. Pauker Effect of Laboratory Variation in the Prothrombin-Time Ratio on the Results of Oral Anticoagulant Therapy N. Engl. J. Med., September 2, 1993; 329(10): 696 - 702. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |